Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type I interferon pathway activation in COPA syndrome.

Stefano Volpi1, Jessica Tsui2, Marcello Mariani3

  • 1Clinica Pediatrica e Reumatologia, Istituto Giannina Gaslini, Genova, Italy; Laboratorio di immunologia delle malattie reumatiche, Istituto Giannina Gaslini, Genova, Italy.

Clinical Immunology (Orlando, Fla.)
|October 15, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The landscape of serum autoantibodies in lupus nephritis.

Autoimmunity reviews·2026
Same author

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

Expert opinion on biological therapy·2026
Same author

Corrigendum to "Redefining ultrasound's role in early diagnosis of hepatosplenic candidiasis during neutropenia: A pediatric case report in solid tumor" [Med. Mycol. Case Rep., 51 (2026) 100777].

Medical mycology case reports·2026
Same author

Congenital cytomegalovirus infection drives oligoclonal expansion of cytotoxic γδ T cells from early fetal progenitors.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion.

bioRxiv : the preprint server for biology·2026
Same author

Single-cell spatial transcriptomics of formalin-fixed, paraffin-embedded biopsies reveals colitis-associated cell networks.

The Journal of clinical investigation·2026

Early intervention is crucial for COPA disease, a genetic immune disorder causing arthritis and lung issues. Prompt treatment can prevent irreversible joint damage and may involve targeting the type 1 interferon pathway.

Area of Science:

  • Immunology
  • Genetics
  • Pulmonology

Background:

  • COPA gene mutations cause a rare immune disorder with polyarticular arthritis and interstitial lung disease.
  • The condition often presents in childhood with significant joint and lung manifestations.

Observation:

  • A case study details a young girl with COPA disease presenting at age 3 with arthritis, cough, and interstitial lung disease.
  • Radiological findings included tree-in-a-bud nodules and air-filled cysts, characteristic of lung involvement.
  • Genetic analysis confirmed a known c.698G>A mutation in the COPA gene.

Findings:

  • Loss to follow-up and discontinued therapy led to joint damage and deformities.
  • Peripheral blood analysis revealed activation of the type 1 interferon pathway.
Keywords:
Autoinflammatory diseasesCOPA syndromeType 1 interferonopathy

Related Experiment Videos

  • This pathway activation was also observed in four previously reported COPA patients.

    • Implications:

    • Early and consistent treatment is vital to preserve joint function in COPA disease.
    • The findings suggest a significant role for type 1 interferon in the disease's development.
    • Targeting the type 1 interferon pathway presents a potential therapeutic strategy for COPA disease.